Overview BMS-214662 in Treating Patients With Solid Tumors Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary Phase I trial to study the effectiveness of BMS-214662 in treating patients who have solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die Phase: Phase 1 Details Lead Sponsor: National Cancer Institute (NCI)